Get the Stockscreener App
4.4465
2.75%
-0.0935
Briacell Therapeutics Corp stock is traded at $4.4465, with a volume of 39,631.
It is down -2.75% in the last 24 hours and up +15.88% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$4.54
Open:
$4.6
24h Volume:
39,631
Relative Volume:
0.09
Market Cap:
$32.01M
Revenue:
-
Net Income/Loss:
$-29.96M
P/E Ratio:
-0.161
EPS:
-27.6253
Net Cash Flow:
$-31.64M
1W Performance:
+7.68%
1M Performance:
+15.88%
6M Performance:
-64.40%
1Y Performance:
+10.10%
1-Day Range:
$4.3666
$4.60
1-Week Range:
$4.04
$4.61
52-Week Range:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.415 | 32.12M | 0 | -29.96M | -31.64M | -27.63 |
VRTX
Vertex Pharmaceuticals Inc
|
442.54 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
760.80 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
803.88 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
325.93 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.01 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Quarterly Earnings: How does BriaCell Therapeutics Corp Equity Warrant compare to its peers2026 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Why Is BriaCell Therapeutics Corp. (BCTX) Stock Down Today? - Meyka
BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal - Mugglehead Magazine
BCTX SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Sentiment Recap: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorRecession Risk & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Technical Analysis: Does BriaCell Therapeutics Corp stock have upside surprise potentialQuarterly Portfolio Review & Risk Managed Investment Entry Signals - baoquankhu1.vn
Published on: 2026-04-01 12:14:35 - baoquankhu1.vn
BriaCell Therapeutics Reports Rising Losses and Funding Pressure - TipRanks
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License - Investing News Network
Earnings Recap: Will BriaCell Therapeutics Corp Equity Warrant stock hit new highs in YEAR2026 Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
BriaCell Therapeutics files interim financial statements for subsidiary By Investing.com - Investing.com India
BriaCell Therapeutics files interim financial statements for subsidiary - Investing.com
BriaCell subsidiary BriaPro posts $472k net loss, $1.61M related-party debt and closes sCD80 license deal - TradingView
BriaCell (NASDAQ: BCTX) unit adds sCD80 license, $3M credit lifeline - Stock Titan
BriaCell Therapeutics Nears Critical Data Readout Following Trial Completion - AD HOC NEWS
Profit Recap: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsPortfolio Update Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Opening: Why is BriaCell Therapeutics Corp stock going down2026 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
Buybacks Report: Does BriaCell Therapeutics Corp have a sustainable dividend2026 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
Momentum Shift: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sector2026 Weekly Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Earnings Report: Should I set a stop loss on BriaCell Therapeutics Corp Equity Warrant2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in Briacell Therapeutics Corp (BCTX) - Stock Titan
BriaCell Therapeutics Corp.: Fundamental Analysis and Financial Ratings | | CA1079303071 - marketscreener.com
Earnings Beat: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsDollar Strength & Reliable Intraday Trade Plans - baoquankhu1.vn
Dip Buying: Is now the right time to enter BriaCell Therapeutics Corp Equity Warrant2026 Highlights & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Portfolio Recap: Is BriaCell Therapeutics Corp a strong candidate for buy and hold2026 Chart Watch & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants debt to equity ratio2026 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Travel Stocks: What is the next catalyst for CRNTProduct Launch & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Treasury Yields: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returns2026 Macro Impact & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Outlook: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
BCTX PE Ratio & Valuation, Is BCTX Overvalued - Intellectia AI
BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeti - GuruFocus
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR - TipRanks
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference - The Manila Times
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference - Bitget
BriaCell to Present Positive Clinical Data for Bria-IMT™ - GlobeNewswire
(BCT) Strategic Investment Guide (BCT:CA) - Stock Traders Daily
BCTX Forecast, Price Target & Analyst Ratings | BRIACELL THERAPEUTICS CORP (NASDAQ:BCTX) - ChartMill
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
Why did BCTX stock surge 50% today? - MSN
BriaCell (NASDAQ: BCTX) boosts cash to fund cancer trials amid higher losses - Stock Titan
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - Yahoo Finance
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
BriaCell (NASDAQ: BCTX) shareholders re-approve equity plan and board slate - Stock Titan
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):